701 related articles for article (PubMed ID: 27045138)
21. SMAD1 deficiency in either endothelial or smooth muscle cells can predispose mice to pulmonary hypertension.
Han C; Hong KH; Kim YH; Kim MJ; Song C; Kim MJ; Kim SJ; Raizada MK; Oh SP
Hypertension; 2013 May; 61(5):1044-52. PubMed ID: 23478097
[TBL] [Abstract][Full Text] [Related]
22. BMPR2 gene delivery reduces mutation-related PAH and counteracts TGF-β-mediated pulmonary cell signalling.
Feng F; Harper RL; Reynolds PN
Respirology; 2016 Apr; 21(3):526-32. PubMed ID: 26689975
[TBL] [Abstract][Full Text] [Related]
23. BMPRII influences the response of pulmonary microvascular endothelial cells to inflammatory mediators.
Vengethasamy L; Hautefort A; Tielemans B; Belge C; Perros F; Verleden S; Fadel E; Van Raemdonck D; Delcroix M; Quarck R
Pflugers Arch; 2016 Nov; 468(11-12):1969-1983. PubMed ID: 27816994
[TBL] [Abstract][Full Text] [Related]
24. Molecular effects of loss of BMPR2 signaling in smooth muscle in a transgenic mouse model of PAH.
Tada Y; Majka S; Carr M; Harral J; Crona D; Kuriyama T; West J
Am J Physiol Lung Cell Mol Physiol; 2007 Jun; 292(6):L1556-63. PubMed ID: 17369292
[TBL] [Abstract][Full Text] [Related]
25. Targeted gene delivery of BMPR2 attenuates pulmonary hypertension.
Reynolds AM; Holmes MD; Danilov SM; Reynolds PN
Eur Respir J; 2012 Feb; 39(2):329-43. PubMed ID: 21737550
[TBL] [Abstract][Full Text] [Related]
26. Raf/ERK drives the proliferative and invasive phenotype of BMPR2-silenced pulmonary artery endothelial cells.
Awad KS; Elinoff JM; Wang S; Gairhe S; Ferreyra GA; Cai R; Sun J; Solomon MA; Danner RL
Am J Physiol Lung Cell Mol Physiol; 2016 Jan; 310(2):L187-201. PubMed ID: 26589479
[TBL] [Abstract][Full Text] [Related]
27. MED1 Regulates BMP/TGF-β in Endothelium: Implication for Pulmonary Hypertension.
Wang C; Xing Y; Zhang J; He M; Dong J; Chen S; Wu H; Huang HY; Chou CH; Bai L; He F; She J; Su A; Wang Y; Thistlethwaite PA; Huang HD; Yuan JX; Yuan ZY; Shyy JY
Circ Res; 2022 Oct; 131(10):828-841. PubMed ID: 36252121
[TBL] [Abstract][Full Text] [Related]
28. Physiologic and molecular consequences of endothelial Bmpr2 mutation.
Majka S; Hagen M; Blackwell T; Harral J; Johnson JA; Gendron R; Paradis H; Crona D; Loyd JE; Nozik-Grayck E; Stenmark KR; West J
Respir Res; 2011 Jun; 12(1):84. PubMed ID: 21696628
[TBL] [Abstract][Full Text] [Related]
29. Gremlin-1 is a key regulator of endothelial-to-mesenchymal transition in human pulmonary artery endothelial cells.
Zhang Y; Zhang M; Xie W; Wan J; Tao X; Liu M; Zhen Y; Lin F; Wu B; Zhai Z; Wang C
Exp Cell Res; 2020 May; 390(1):111941. PubMed ID: 32145252
[TBL] [Abstract][Full Text] [Related]
30. Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension.
Hautefort A; Mendes-Ferreira P; Sabourin J; Manaud G; Bertero T; Rucker-Martin C; Riou M; Adão R; Manoury B; Lambert M; Boet A; Lecerf F; Domergue V; Brás-Silva C; Gomez AM; Montani D; Girerd B; Humbert M; Antigny F; Perros F
Circulation; 2019 Feb; 139(7):932-948. PubMed ID: 30586714
[TBL] [Abstract][Full Text] [Related]
31. Oestrogen receptor alpha in pulmonary hypertension.
Wright AF; Ewart MA; Mair K; Nilsen M; Dempsie Y; Loughlin L; Maclean MR
Cardiovasc Res; 2015 May; 106(2):206-16. PubMed ID: 25765937
[TBL] [Abstract][Full Text] [Related]
32. [Bone morphogenetic protein type II receptor gene promoter mutation-142G > A in a patient with familial pulmonary arterial hypertension].
Li W; Hu H
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):230-4. PubMed ID: 19552837
[TBL] [Abstract][Full Text] [Related]
33. Endothelial HIF-2α contributes to severe pulmonary hypertension due to endothelial-to-mesenchymal transition.
Tang H; Babicheva A; McDermott KM; Gu Y; Ayon RJ; Song S; Wang Z; Gupta A; Zhou T; Sun X; Dash S; Wang Z; Balistrieri A; Zheng Q; Cordery AG; Desai AA; Rischard F; Khalpey Z; Wang J; Black SM; Garcia JGN; Makino A; Yuan JX
Am J Physiol Lung Cell Mol Physiol; 2018 Feb; 314(2):L256-L275. PubMed ID: 29074488
[TBL] [Abstract][Full Text] [Related]
34. Elafin Reverses Pulmonary Hypertension via Caveolin-1-Dependent Bone Morphogenetic Protein Signaling.
Nickel NP; Spiekerkoetter E; Gu M; Li CG; Li H; Kaschwich M; Diebold I; Hennigs JK; Kim KY; Miyagawa K; Wang L; Cao A; Sa S; Jiang X; Stockstill RW; Nicolls MR; Zamanian RT; Bland RD; Rabinovitch M
Am J Respir Crit Care Med; 2015 Jun; 191(11):1273-86. PubMed ID: 25853696
[TBL] [Abstract][Full Text] [Related]
35. The LPS induced pyroptosis exacerbates BMPR2 signaling deficiency to potentiate SLE-PAH.
Xing Y; Zhao J; Zhou M; Jing S; Zhao X; Mao P; Qian J; Huang C; Tian Z; Wang Q; Zeng X; Li M; Yang J
FASEB J; 2021 Dec; 35(12):e22044. PubMed ID: 34818449
[TBL] [Abstract][Full Text] [Related]
36. Receptor for activated C-kinase 1, a novel interaction partner of type II bone morphogenetic protein receptor, regulates smooth muscle cell proliferation in pulmonary arterial hypertension.
Zakrzewicz A; Hecker M; Marsh LM; Kwapiszewska G; Nejman B; Long L; Seeger W; Schermuly RT; Morrell NW; Morty RE; Eickelberg O
Circulation; 2007 Jun; 115(23):2957-68. PubMed ID: 17515463
[TBL] [Abstract][Full Text] [Related]
37. Endothelial-to-Mesenchymal Transition in Pulmonary Arterial Hypertension.
Gorelova A; Berman M; Al Ghouleh I
Antioxid Redox Signal; 2021 Apr; 34(12):891-914. PubMed ID: 32746619
[TBL] [Abstract][Full Text] [Related]
38. BMPR2 preserves mitochondrial function and DNA during reoxygenation to promote endothelial cell survival and reverse pulmonary hypertension.
Diebold I; Hennigs JK; Miyagawa K; Li CG; Nickel NP; Kaschwich M; Cao A; Wang L; Reddy S; Chen PI; Nakahira K; Alcazar MA; Hopper RK; Ji L; Feldman BJ; Rabinovitch M
Cell Metab; 2015 Apr; 21(4):596-608. PubMed ID: 25863249
[TBL] [Abstract][Full Text] [Related]
39. Endothelial
Theilmann AL; Hawke LG; Hilton LR; Whitford MKM; Cole DV; Mackeil JL; Dunham-Snary KJ; Mewburn J; James PD; Maurice DH; Archer SL; Ormiston ML
Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2605-2618. PubMed ID: 32998516
[TBL] [Abstract][Full Text] [Related]
40. Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension.
Teichert-Kuliszewska K; Kutryk MJ; Kuliszewski MA; Karoubi G; Courtman DW; Zucco L; Granton J; Stewart DJ
Circ Res; 2006 Feb; 98(2):209-17. PubMed ID: 16357305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
